Exploring the immune landscape of anal squamous cell carcinoma and the therapeutic utility of immunotherapies

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1133019

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Anal cancer has been on the rise without improvements in patient treatment or survival over the last three decades. Immunotherapy which uses a patient's immune system to combat cancer has demonstrated great success in the treatment of several tumours, and consequently demands investigation for patients with anal cancer. This project is focussed on examining the immune system's role in anal cancer, and whether immunotherapies can be used to improved treatment response and patient survival.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2018

Funding Scheme: Postgraduate Scholarships

Funding Amount: $48,791.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anal cancer | cancer immunology | cancer immunotherapy | mouse models | pre-clinical studies

Related Links